BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11367981)

  • 1. [HDL metabolism].
    Genschel J; Schmidt HH
    Z Gastroenterol; 2001 Apr; 39(4):321-7. PubMed ID: 11367981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease.
    Brewer HB
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):387-91. PubMed ID: 15003970
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease.
    Barter PJ; Kastelein JJ
    J Am Coll Cardiol; 2006 Feb; 47(3):492-9. PubMed ID: 16458126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HDL and reverse cholesterol transport. Role of cholesterol ester transfer protein].
    Lagrost L; Gambert P
    C R Seances Soc Biol Fil; 1992; 186(4):405-13. PubMed ID: 1301229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia.
    Inazu A; Koizumi J; Mabuchi H; Kajinami K; Takeda R
    Horm Metab Res; 1992 Jun; 24(6):284-8. PubMed ID: 1634194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.
    Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE
    Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of the high-density lipoprotein (HDL) particle in atherogenesis and potential methods to increase HDL concentrations].
    Birjmohun RS; van der Steeg WA; Stroes ES; Kastelein JJ
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2245-50. PubMed ID: 17076358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet and waist-to-hip ratio: important predictors of lipoprotein levels in sedentary and active young men with no evidence of cardiovascular disease.
    Mansfield E; McPherson R; Koski KG
    J Am Diet Assoc; 1999 Nov; 99(11):1373-9. PubMed ID: 10570674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL as a target in the treatment of atherosclerotic cardiovascular disease.
    Linsel-Nitschke P; Tall AR
    Nat Rev Drug Discov; 2005 Mar; 4(3):193-205. PubMed ID: 15738977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholesterol ester transfer protein. A major player in cholesterol metabolism].
    Hansen PR
    Ugeskr Laeger; 1999 Sep; 161(38):5295-8. PubMed ID: 10536513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits.
    Okamoto H; Yonemori F; Wakitani K; Minowa T; Maeda K; Shinkai H
    Nature; 2000 Jul; 406(6792):203-7. PubMed ID: 10910363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The possible role of genetic factors in the cholesterol high density lipoprotein level in the Moscow population].
    Slominskiĭ PA; Metel'skaia VA; Miloserdova OV; Perova NV; Limborskaia SA
    Genetika; 2000 Oct; 36(10):1401-5. PubMed ID: 11094754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on cholesteryl ester transfer activity in coronary heart disease.
    Fujinuma Y; Tanaka A; Maezawa H
    Bull Tokyo Med Dent Univ; 1991 Sep; 38(3):27-33. PubMed ID: 1934199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoprotein cholesterol: ready for prime time?
    Kon YC
    Singapore Med J; 2005 Oct; 46(10):507-13. PubMed ID: 16172769
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R; Hilliquin P
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors for atherosclerotic vascular disease in patients on maintenance hemodialysis--with especial respect to reverse cholesterol transport system and hyperhomocysteinemia].
    Kimura H; Yoshida H
    Rinsho Byori; 2002 Aug; 50(8):793-801. PubMed ID: 12373816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential for CETP inhibition to reduce cardiovascular disease risk.
    Ansell B; Hobbs FD
    Curr Med Res Opin; 2006 Dec; 22(12):2467-78. PubMed ID: 17257461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer protein.
    Post SM; de Crom R; van Haperen R; van Tol A; Princen HM
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):892-7. PubMed ID: 12649089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoprotein cholesterol-raising strategies.
    Kuvin JT; Alsheikh-Ali AA; Karas RH
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):196-204. PubMed ID: 16495756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.